-
2
-
-
0036178655
-
Available guidance and best practices for conducting forced degradation studies
-
Reynolds D.W., Facchine K.L., Mullaney J.F., Alsante K.M., Hatajik T.D., and Motto M.G. Available guidance and best practices for conducting forced degradation studies. Pharmaceutical Technology 26 2 (2002) 48-54
-
(2002)
Pharmaceutical Technology
, vol.26
, Issue.2
, pp. 48-54
-
-
Reynolds, D.W.1
Facchine, K.L.2
Mullaney, J.F.3
Alsante, K.M.4
Hatajik, T.D.5
Motto, M.G.6
-
3
-
-
9644255888
-
Guidance for industry INDs for phase 2 and phase 3 studies, chemistry, manufacturing and controls information
-
FDA. Guidance for industry INDs for phase 2 and phase 3 studies, chemistry, manufacturing and controls information. Federal Register 68 (2003) 27567-27568
-
(2003)
Federal Register
, vol.68
, pp. 27567-27568
-
-
FDA1
-
4
-
-
33846800846
-
Submitting Documentation for the Stability of Human Drugs and Biologics
-
FDA. Submitting Documentation for the Stability of Human Drugs and Biologics. CDER (February 1987)
-
(1987)
CDER
-
-
FDA1
-
5
-
-
84955853469
-
-
Jorgensen W.L., Laird E.R., Gushurst A.J., Fleischer J.M., Gothe S.A., Helson H.E., Paderes G.D., and Sinclair S. Pure and Applied Chemistry 62 (1990) 1921-1932
-
(1990)
Pure and Applied Chemistry
, vol.62
, pp. 1921-1932
-
-
Jorgensen, W.L.1
Laird, E.R.2
Gushurst, A.J.3
Fleischer, J.M.4
Gothe, S.A.5
Helson, H.E.6
Paderes, G.D.7
Sinclair, S.8
-
6
-
-
79959540263
-
Degradation and impurity analysis for pharmaceutical drug candidates (Chapter 4)
-
Ahuja S., and Scypinski S. (Eds), Academic Press, Boston
-
Alsante K.M., Friedmann R.C., Hatajik T.D., Lohr L.L., Sharp T.R., Snyder K.D., and Szczesny E.J. Degradation and impurity analysis for pharmaceutical drug candidates (Chapter 4). In: Ahuja S., and Scypinski S. (Eds). Handbook of Modern Pharmaceutical Analysis (2001), Academic Press, Boston 85-172
-
(2001)
Handbook of Modern Pharmaceutical Analysis
, pp. 85-172
-
-
Alsante, K.M.1
Friedmann, R.C.2
Hatajik, T.D.3
Lohr, L.L.4
Sharp, T.R.5
Snyder, K.D.6
Szczesny, E.J.7
-
7
-
-
3042826837
-
Forced degradation of pharmaceuticals
-
Reynolds D.W. Forced degradation of pharmaceuticals. American Pharmaceutical Review 7 3 (2004) 56-61
-
(2004)
American Pharmaceutical Review
, vol.7
, Issue.3
, pp. 56-61
-
-
Reynolds, D.W.1
-
8
-
-
0036395858
-
Stabilization of pharmaceuticals to oxidative degradation
-
Waterman K.C., Adami R.C., Alsante K.M., Hong J., Landis M.S., Lombardo F., and Roberts C.J. Stabilization of pharmaceuticals to oxidative degradation. Pharmaceutical Development and Technology 7 1 (2002) 1-32
-
(2002)
Pharmaceutical Development and Technology
, vol.7
, Issue.1
, pp. 1-32
-
-
Waterman, K.C.1
Adami, R.C.2
Alsante, K.M.3
Hong, J.4
Landis, M.S.5
Lombardo, F.6
Roberts, C.J.7
-
9
-
-
0001184884
-
Guideline for the photostability testing of new drug substances and new drug products
-
FDA. Guideline for the photostability testing of new drug substances and new drug products. Federal Register 62 95 (May 16 1997) 27115-27122
-
(1997)
Federal Register
, vol.62
, Issue.95
, pp. 27115-27122
-
-
FDA1
-
10
-
-
33747891589
-
Role of "Mass Balance" in pharmaceutical stress testing
-
Baertschi S.W. (Ed), Taylor and Francis Group, New York
-
Nussbaum M.A., Jansen P.J., and Baertschi S.W. Role of "Mass Balance" in pharmaceutical stress testing. In: Baertschi S.W. (Ed). Pharmaceutical Stress testing: Understanding Drug Degradation (2005), Taylor and Francis Group, New York 181-204
-
(2005)
Pharmaceutical Stress testing: Understanding Drug Degradation
, pp. 181-204
-
-
Nussbaum, M.A.1
Jansen, P.J.2
Baertschi, S.W.3
-
12
-
-
33846791254
-
Theoretical analysis of solid-state chemical reactions
-
Byrn S.J., Pfeiffer R.R., and Stowell J.G. (Eds), SSCI, Inc., West Lafayette, Indiana
-
Byrn S.J., Pfeiffer R.R., and Stowell J.G. Theoretical analysis of solid-state chemical reactions. In: Byrn S.J., Pfeiffer R.R., and Stowell J.G. (Eds). Solid State Chemistry of Drugs. Second edition (1999), SSCI, Inc., West Lafayette, Indiana 307
-
(1999)
Solid State Chemistry of Drugs. Second edition
, pp. 307
-
-
Byrn, S.J.1
Pfeiffer, R.R.2
Stowell, J.G.3
-
13
-
-
33846831770
-
-
K.M. Alsante, T.D. Hatajik, D. Santafianos, T.S. Sharp, L.L. Lohr, Impurity isolation and characterization case studies, in: S. Ahuja, K.M. Alsante (Eds.), Handbook of Isolation and Characterization of Impurities in Pharmaceuticals, Academic Press (Elsevier), New York, 2003, pp. 361-400.
-
-
-
-
14
-
-
33846800844
-
Applications development using out-of-the-box software: a structure searchable degradation/impurity database
-
Alsante K.M., Snyder K.D., Swartz M., and Parks C. Applications development using out-of-the-box software: a structure searchable degradation/impurity database. Scientific Computing and Instrumentation (June 2002) 30-37
-
(2002)
Scientific Computing and Instrumentation
, pp. 30-37
-
-
Alsante, K.M.1
Snyder, K.D.2
Swartz, M.3
Parks, C.4
-
15
-
-
33846832347
-
Selecting light-resistant containers
-
Abendroth R.P. Selecting light-resistant containers. ChromConnection (July 1994) 4-6
-
(1994)
ChromConnection
, pp. 4-6
-
-
Abendroth, R.P.1
|